Impacto económico de la diabetes y sus principales complicaciones en Argentina.
Saved in:
| Title: | Impacto económico de la diabetes y sus principales complicaciones en Argentina. |
|---|---|
| Alternate Title: | Economic impact of diabetes and its main complications in Argentina. |
| Authors: | Dieuzeide, Guillermo1 (AUTHOR) dieuzeideg@gmail.com, Pugnaloni, Natalia2 (AUTHOR), Zambon, Fabio2 (AUTHOR), Delfino, Matías2 (AUTHOR), Xynos, Georgina2 (AUTHOR), Martínez, Elizabeth2 (AUTHOR), Tabares, Marina3 (AUTHOR) |
| Source: | Medicina (Buenos Aires). jul/ago2025, Vol. 85 Issue 4, p743-753. 11p. |
| Subjects: | DIABETES, TYPE 2 diabetes, ECONOMIC impact, MEDICAL care costs, CHRONIC diseases, CARDIOVASCULAR diseases, COUNTRIES, DISEASE complications |
| Geographic Terms: | ARGENTINA |
| Abstract (English): | Introduction: Cardiovascular disease is the leading cause of mortality in patients with type 2 diabetes mellitus (T2DM). Its weighted prevalence in argentine patients is 41.5%.The aim of this study was to estimate the direct medical costs associated with the treatment and follow-up of T2DM, in addition to its main chronic complications. Materials and methods: Micro-costing analysis to calculate and estimate the frequency of resource use and to determine the overall cost in Argentine pesos (ARS; August 2022) of the T2DM related complications de scribed in the Argentinean population of CAPTURE study. Results: The estimated annual direct cost for the follow-up and treatment of T2DM per patient was ARS 252 899.45 (United States dollars [USD] 1774.48) in the so cial security subsector and ARS 257 799.10 (USD 1808.86) in the private subsector. Stroke was the most expensive diabetes-related complication. As the complexity of care increased, there was a relative decrease in medication cost, with concomitant increases in the cost of inter ventions. When considering the cost of treatment for uncomplicated T2DM as a baseline parameter, cardio vascular, renal, and cerebrovascular events multiplied this value by up to 9.9, 8.4, and 47.8 times, respectively. Discussion: The significant economic burden of T2DM complications in the Argentine healthcare system, both in the social security and the private sectors, highlights the importance of understanding these costs to make effective strategic decisions regarding disease manage ment and population health policy planning. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): | Introducción: La enfermedad cardiovascular es la principal causa de mortalidad en pacientes con diabe tes mellitus tipo 2 (DM2). Su prevalencia ponderada en Argentina es del 41.5%. El objetivo del presente estudio fue estimar los costos médicos directos del tratamiento y seguimiento de la DM2 y de las principales complica ciones crónicas asociadas. Materiales y métodos: Análisis de microcosteo, con cálculo y estimación de la frecuencia de uso de recursos y obtención del costo global en pesos argentinos (ARS; agosto de 2022), de las complicaciones relacionadas a la DM2 descriptas en la población argentina del estudio CAPTURE. Resultados: El costo directo anual estimado para el seguimiento y tratamiento de un paciente con DM2 fue de ARS 252 899.45 (1774.48 dólares estadounidenses [USD]) para el subsector de la seguridad social y de ARS 257 799.10 (USD 1808.86) para el subsector privado. El acci dente cerebrovascular fue la complicación más costosa. A medida que aumentaba la complejidad de la atención, se observó una reducción relativa del gasto en medicación, a expensas de un incremento en las intervenciones. Toman do como parámetro de base el costo de tratamiento de la DM2 sin complicaciones, los eventos cardiovasculares, renales y cerebrovasculares multiplicaron dicho valor hasta por 9.9, 8.4 y 47.8 veces, respectivamente. Discusión: La carga económica significativa de las complicaciones de la DM2 en el sistema de salud ar gentino, tanto en la seguridad social como en el sector privado, resalta la importancia de conocer estos costos para tomar decisiones estratégicas efectivas en el ma nejo de la enfermedad y en la planificación de políticas de salud a nivel poblacional. [ABSTRACT FROM AUTHOR] |
| Copyright of Medicina (Buenos Aires) is the property of Medicina (Buenos Aires) and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | MedicLatina |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Introduction: Cardiovascular disease is the leading cause of mortality in patients with type 2 diabetes mellitus (T2DM). Its weighted prevalence in argentine patients is 41.5%.The aim of this study was to estimate the direct medical costs associated with the treatment and follow-up of T2DM, in addition to its main chronic complications. Materials and methods: Micro-costing analysis to calculate and estimate the frequency of resource use and to determine the overall cost in Argentine pesos (ARS; August 2022) of the T2DM related complications de scribed in the Argentinean population of CAPTURE study. Results: The estimated annual direct cost for the follow-up and treatment of T2DM per patient was ARS 252 899.45 (United States dollars [USD] 1774.48) in the so cial security subsector and ARS 257 799.10 (USD 1808.86) in the private subsector. Stroke was the most expensive diabetes-related complication. As the complexity of care increased, there was a relative decrease in medication cost, with concomitant increases in the cost of inter ventions. When considering the cost of treatment for uncomplicated T2DM as a baseline parameter, cardio vascular, renal, and cerebrovascular events multiplied this value by up to 9.9, 8.4, and 47.8 times, respectively. Discussion: The significant economic burden of T2DM complications in the Argentine healthcare system, both in the social security and the private sectors, highlights the importance of understanding these costs to make effective strategic decisions regarding disease manage ment and population health policy planning. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 00257680 |
